1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. North America Glaucoma Therapeutics Market Landscape

4.1 Overview

4.2 PEST Analysis

5. North America Glaucoma Therapeutics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Mounting Incidence of Glaucoma Disease

5.1.2 Increasing Number of Product Launches, Collaborations, and Acquisitions

5.2 Market Restraints

5.2.1 Medication Regimen Compliance Issues

5.3 Market Opportunities

5.3.1 Development of Wearable Technologies

5.4 Future Trends

5.4.1 Development of Novel Drug Delivery Methods

5.5 Impact of Drivers and Restraints:

6. Glaucoma Therapeutics Market - North America Analysis

6.1 Glaucoma Therapeutics Market Revenue (US$ Million), 2021-2031

6.2 Glaucoma Therapeutics Market Forecast Analysis

7. North America Glaucoma Therapeutics Market Analysis - by Drug Class

7.1 Beta Blockers

7.1.1 Overview

7.1.2 Beta Blockers: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

7.2 Alpha Adrenergic Agonists

7.2.1 Overview

7.2.2 Alpha Adrenergic Agonists: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Prostaglandins Analogues

7.3.1 Overview

7.3.2 Prostaglandins Analogues: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Carbonic Anhydrase Inhibitors

7.4.1 Overview

7.4.2 Carbonic Anhydrase Inhibitors: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

7.5 Combination Drugs

7.5.1 Overview

7.5.2 Combination Drugs: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Glaucoma Therapeutics Market Analysis - by Indication

8.1 Open Angle Glaucoma

8.1.1 Overview

8.1.2 Open Angle Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

8.2 Angle Closure Glaucoma

8.2.1 Overview

8.2.2 Angle Closure Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Glaucoma Therapeutics Market Analysis - by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview

9.1.2 Hospital Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview

9.2.2 Retail Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview

9.3.2 Online Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Glaucoma Therapeutics Market - Country Analysis

10.1 North America

10.1.1 North America: Glaucoma Therapeutics Market Breakdown, by Key Country, 2023 and 2031 (%)

10.1.1.1 North America: Glaucoma Therapeutics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 United States: Glaucoma Therapeutics Market Breakdown, by Drug Class

10.1.1.2.2 United States: Glaucoma Therapeutics Market Breakdown, by Indication

10.1.1.2.3 United States: Glaucoma Therapeutics Market Breakdown, by Distribution Channel

10.1.1.3 Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 Canada: Glaucoma Therapeutics Market Breakdown, by Drug Class

10.1.1.3.2 Canada: Glaucoma Therapeutics Market Breakdown, by Indication

10.1.1.3.3 Canada: Glaucoma Therapeutics Market Breakdown, by Distribution Channel

10.1.1.4 Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

10.1.1.4.1 Mexico: Glaucoma Therapeutics Market Breakdown, by Drug Class

10.1.1.4.2 Mexico: Glaucoma Therapeutics Market Breakdown, by Indication

10.1.1.4.3 Mexico: Glaucoma Therapeutics Market Breakdown, by Distribution Channel

11. Glaucoma Therapeutics Market - Industry Landscape

11.1 Growth Strategies in Glaucoma Therapeutics Market

11.2 Organic Growth Strategies

11.2.1 Overview

11.3 Inorganic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Alcon AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 AbbVie Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bausch & Lomb Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Fera Pharmaceuticals, LLC

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Viatris Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Novartis AG

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Sun Pharmaceutical Industries Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Teva Pharmaceutical Industries Ltd

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Thea Pharma Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Santen Pharmaceutical Co., Ltd.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. North America Glaucoma Therapeutics Market Segmentation

Table 2. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Table 3. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Class

Table 4. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 5. Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 6. North America: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Country

Table 7. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Class

Table 8. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 9. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 10. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Class

Table 11. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 12. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 13. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Class

Table 14. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Indication

Table 15. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 16. Recent Organic Growth Strategies in Glaucoma Therapeutics Market

Table 17. Recent Inorganic Growth Strategies in the Glaucoma Therapeutics Market

Table 18. Glossary of Terms

List of Figures

Figure 1. North America Glaucoma Therapeutics Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Glaucoma Therapeutics Market - Key Market Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Glaucoma Therapeutics Market Revenue (US$ Million), 2021-2031

Figure 6. Glaucoma Therapeutics Market Share (%) - by Drug Class (2023 and 2031)

Figure 7. Beta Blockers: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Alpha Adrenergic Agonists: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 9. Prostaglandins Analogues: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Carbonic Anhydrase Inhibitors: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Combination Drugs: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 12. Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Glaucoma Therapeutics Market Share (%) - by Indication (2023 and 2031)

Figure 14. Open Angle Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 15. Angle Closure Glaucoma: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Others: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Glaucoma Therapeutics Market Share (%) - by Distribution Channel (2023 and 2031)

Figure 18. Hospital Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Retail Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Online Pharmacy: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 21. North America Glaucoma Therapeutics Market, by Key Country - Revenue (2023) (US$ Million)

Figure 22. North America: Glaucoma Therapeutics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. United States: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Canada: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 25. Mexico: Glaucoma Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)

Figure 26. Growth Strategies in Glaucoma Therapeutics Market